Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02869633
What this trial is testing

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

Who this might be right for
Blastoid Variant Mantle Cell LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Follicular Lymphoma+6 more
Vanderbilt-Ingram Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00616720
What this trial is testing

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 15
Testing effectiveness (Phase 2)UnknownNCT02145923
What this trial is testing

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Who this might be right for
Neutropenic EnterocolitisMyeloablative Chemotherapy Induced Bone Marrow Aplasia
Burnasyan Federal Medical Biophysical Center 16
Testing effectiveness (Phase 2)Study completedNCT00587054
What this trial is testing

Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders

Who this might be right for
Allogeneic Stem Cell TransplantLeukemiaNon-Hodgkins+3 more
Memorial Sloan Kettering Cancer Center 129
Not applicableLooking for participantsNCT05794880
What this trial is testing

MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing

Who this might be right for
LeukemiaAcute Myeloid Leukemia in RemissionMyelodysplasia+10 more
Medical College of Wisconsin 40
Not applicableActive Not RecruitingNCT04108624
What this trial is testing

Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
University of Chicago 68
Testing effectiveness (Phase 2)Ended earlyNCT02794246
What this trial is testing

CART-19 Post-ASCT for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 6
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Ended earlyNCT00275262
What this trial is testing

Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Who this might be right for
Hodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma+1 more
Abbott 25
Large-scale testing (Phase 3)Looking for participantsNCT06895538
What this trial is testing

Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

Who this might be right for
LeukemiaMDSLymphoma
Peking University First Hospital 24
Testing effectiveness (Phase 2)Looking for participantsNCT06376526
What this trial is testing

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dickran Kazandjian, MD 150
Testing effectiveness (Phase 2)Ended earlyNCT01195480
What this trial is testing

CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
University College, London 29
Early research (Phase 1)Study completedNCT04634435
What this trial is testing

Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biohaven Pharmaceuticals, Inc. 7
Early research (Phase 1)Study completedNCT01158274
What this trial is testing

RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAIDS-related Diffuse Large Cell Lymphoma+83 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT02512497
What this trial is testing

Romidepsin Maintenance After Allogeneic Stem Cell Transplantation

Who this might be right for
Cutaneous T-cell LymphomaT-Prolymphocytic LeukemiaT-Large Granulocytic Leukemia+2 more
Ohio State University Comprehensive Cancer Center 23
Not applicableStudy completedNCT00569309
What this trial is testing

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma

Who this might be right for
LymphomaMultiple Myeloma and Plasma Cell NeoplasmSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT01172132
What this trial is testing

The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH"

Who this might be right for
Hematological Malignancies
Assistance Publique - Hôpitaux de Paris 1,011
Large-scale testing (Phase 3)Study completedNCT01016548
What this trial is testing

Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy

Who this might be right for
LymphomaMultiple MyelomaInfluenza A Virus, H1N1 Subtype
University Health Network, Toronto 42
Very early researchStudy completedNCT01174940
What this trial is testing

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

Who this might be right for
Stem Cell Leukemia of Unclear LineageGraft Versus Host Disease
University of Kansas Medical Center 22
Next Page